Thrombolysis and antiplatelet agents
π
Article
π
1991
π
Springer US
π
English
β 327 KB
To assess potential benefits of rt-PA in addition to heparin (HEP) and aspirin (ASP) given early in acute myocardial infarction (MI), 61 pts were randomised double-blind after admission to either rt-PA 100 mgs IV over 3 hrs plus 1,000 U/hr HEP for 24 hrs plus 300 rags ASP daily (n=46) or HEP plus AS